Loading
Zdravka Medarova

Zdravka Medarova

Chief Scientific Officer, TransCode Therapeutics
United States
Zdravka Medarova, PhD is Co-Founder and Chief Scientific Officer at TransCode Therapeutics, Inc. Dr. Medarova is a geneticist/ cancer biologist by training and is internationally recognized for her work on non-coding RNA for cancer therapy. She is one of the first to describe the design and application of nanoparticles as carries of siRNA to tumors. Dr. Medarova obtained a B.A. in pre medicine from the University of South Maine in September 1998 and a Ph.D. in Genetics from the University of New Hampshire in December 2001. Prior to joining TransCode, Dr. Medarova served as an Associate Professor of Radiology at Harvard Medical School and an Assistant in Neuroimaging at the Massachusetts General Hospital.
Sessions

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS